Larry M. Simonsmeier Writing Award
The American Society for Pharmacy Law (ASPL) is a nationwide organization with the purposes of: (i) furthering knowledge in the law related to pharmacists, pharmacies, the provision of pharmaceutical care, the manufacturing and distribution of drugs, and other food, drug, and medical device policy issues ("Pharmacy Law"); (ii) communicating accurate legal educational information; and (iii) providing education opportunities for pharmacists, attorneys, and others who are interested in Pharmacy Law.
ASPL recognizes outstanding scholarship related to Pharmacy Law with the Simonsmeier Award. The Award recognizes an outstanding paper relating to the interests of ASPL published during the prior two years (2013-2015). The 2016 Award includes an honorarium plus support for travel to the ASPL Developments in Pharmacy Law Seminar XXVII in Austin, Texas, November 9-13, 2016.
The Award is named in honor of the late Larry Simonsmeier (1944-2009), who was a pharmacist and attorney, professor and dean of Washington State University College of Pharmacy, president of ASPL, and editor of the Rx Ipsa Loquitur for more than twenty years.
Papers related to Pharmacy Law, as defined above, published in or accepted for publication in any English-language peer-reviewed journal (including law reviews) during the period from January 2013 through December 2015 are eligible. Interested parties are invited to nominate published papers written by themselves or other authors. Authors may submit manuscripts that are in press.
Submission of Nominations
Nominations should provide the name, address, daytime telephone number, and e-mail address of the nominator, a reprint of the full paper, and a complete journal citation for the paper being nominated. If an author is submitting a manuscript that is in press, the copy of the manuscript should be accompanied by documentation from the journal editor of the status of the paper, and should include contact information for the journal editor. The deadline for submission of nominations for the Larry M. Simonsmeier Award is June 30, 2016.
Nominations should be addressed to:
Education & Scholarship Committee
Questions may be directed to ASPL at:
July 22, 2016
FDA publishes notices to pharmacies of changes in its inspection procedures for pharmacies compounding under §503A
On July 12, the FDA published a notice that it will adopt revised procedures effective August 1, 2016, when it inspects pharmacies that are compounding drugs in accordance with state laws under §503A of the FDCA. Under the revised procedure, when an FDA investigator conducts an inspection and determines that he or she should issue a "Form FDA-483," the investigator shall first "make a preliminary assessment of whether such entities are compounding their human drugs in accordance with certain conditions of section 503A before closing the inspection." Read more
2016 DPLXXVII Seminar
November 10-13, 2016